HCPCS Level II drug code
J1162 — Injection, digoxin immune fab (ovine), per vial
In short
J1162 is the HCPCS Level II code for injection, digoxin immune fab (ovine), per vial. CMS assigns NDCs for Digifab to it. The Medicare Part B payment limit is $5,711.373 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, digoxin immune fab (ovine), per vial
- Short descriptor
- Digoxin immune fab (ovine)
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2006
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Inflation-adjusted coinsurance. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J1162
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J1162 for Digifab. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Digifab | 50633-0120-11 | BTG International Inc. | 1 | 1 |
| Digifab | 87131-0120-11 | Salvagenix, Inc. | 1 | 1 |
J1162: common questions
- Is J1162 a CPT code?
- No. J1162 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J1162?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 2 NDCs under J1162, for Digifab. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J1162?
- $5,711.373 per per vial, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.